Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematopoietic Stem Cell Transplantation, Graft-Versus-Host Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT00361413
What this trial is testing

Alefacept for Prevention of Graft Versus Host Disease (GVHD)

Who this might be right for
Graft Versus Host Disease
Hadassah Medical Organization 26
Large-scale testing (Phase 3)WithdrawnNCT03066466
What this trial is testing

Randomized Study: Standard of Care With or Without Atorvastatin for Prevention of GVHD for Matched Unrelated Donor BMT

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphocytic LeukemiaMyelodysplastic Syndrome
Loyola University
Testing effectiveness (Phase 2)Looking for participantsNCT07246031
What this trial is testing

BPC2001 for the Prevention of Acute Graft-Versus-Host Disease Following Haploidentical Stem Cell Transplantation

Who this might be right for
Graft -Versus-host-diseaseaGVHDHaploidentical Stem Cell Transplantation+1 more
BioPhoenix Co., Ltd. 50
Testing effectiveness (Phase 2)Ended earlyNCT00032773
What this trial is testing

Dose-finding Study Using Pentostatin for Injection in the Treatment of Steroid-refractory aGvHD

Who this might be right for
Acute Graft Versus Host Disease
Astex Pharmaceuticals, Inc. 36
Testing effectiveness (Phase 2)Looking for participantsNCT06252870
What this trial is testing

Study Testing Two Conditioning Regimen With a Single Prophylaxis of GVHD by Cyclophosphamide and Methotrexate Post-transplant in Patients Eligible for Matched-donor Allograft Transplantation

Who this might be right for
Graft Versus Host DiseaseHematologic Malignancy
Nantes University Hospital 82
Testing effectiveness (Phase 2)UnknownNCT01428973
What this trial is testing

Minitransplants With HLA-matched Donors : Comparison Between 2 GVHD Prophylaxis Regimens

Who this might be right for
Graft-Versus-Host DiseaseHematological Malignancies
University of Liege 200
Not applicableLooking for participantsNCT05236062
What this trial is testing

Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART Trial

Who this might be right for
Graft Vs Host DiseaseAcute-graft-versus-host DiseaseChronic Graft-versus-host-disease
Dana-Farber Cancer Institute 36
Early research (Phase 1)Study completedNCT03018223
What this trial is testing

Calcineurin Inhibitor-Free GVHD Prevention Regimen After Related Haplo PBSCT

Who this might be right for
Non-Hodgkin's LymphomaAcute Leukemia in RemissionChronic Myeloid Leukemia+5 more
H. Lee Moffitt Cancer Center and Research Institute 32
Testing effectiveness (Phase 2)Ended earlyNCT03717480
What this trial is testing

Ex Vivo TCR αβ T Cell Depletion for Graft-Versus-Host Disease Prophylaxis in Mismatched Donor Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies

Who this might be right for
Hematologic Malignancy
Dana-Farber Cancer Institute 2
Not applicableStudy completedNCT04838704
What this trial is testing

Ruxolitinib With Calcineurin Inhibitor and Methotrexate vs. Calcineurin Inhibitor Plus Methotrexate and Mycophenolate Mofetil as Graft Versus Host Disease Prophylaxis for HLA-haploidentical Hematopoietic Stem Cell Transplantation

Who this might be right for
Graft Versus Host Disease
Zhejiang University 215
Not applicableLooking for participantsNCT06247150
What this trial is testing

Tissue Immune Landscape of Graft Versus Host Disease After Allogeneic Stem Cell Transplantation (TIL-GVHD)

Who this might be right for
Chronic Graft Versus Host Disease
University Hospital, Bordeaux 70
Very early researchStudy completedNCT00612274
What this trial is testing

Sirolimus, Tacrolimus and Short Course Methotrexate for Prevention of Acute GVHD in Recipients of Mismatched Unrelated Donor Allogeneic Stem Cell Transplantation

Who this might be right for
Stem Cell Transplantation
Yale University 26
Testing effectiveness (Phase 2)Looking for participantsNCT07285889
What this trial is testing

First-Line Jaktinib for Acute Graft-Versus-Host Disease (aGVHD)

Who this might be right for
Acute Graft Versus Host Disease
First Affiliated Hospital of Zhejiang University 35
Not applicableNo Longer AvailableNCT03172455
What this trial is testing

Early Access Program Using Alpha 1 Antitrypsin Infusion for Patients With Steroid Refractory Acute GvHD After Hematopoietic Stem Cell Transplantation (HSCT)

Who this might be right for
Acute-graft-versus-host DiseaseSteroid Refractory Acute Graft Versus Host DiseaseGraft-versus-host-disease+5 more
Impatients N.V. trading as myTomorrows
Early research (Phase 1)Looking for participantsNCT07025538
What this trial is testing

Biomarker-Guided Ruxolitinib for the Prevention of Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Hematopoietic and Lymphatic System Neoplasm
City of Hope Medical Center 42
Large-scale testing (Phase 3)Active Not RecruitingNCT05515029
What this trial is testing

Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Calcineurin Inhibitor at Patients With Hemoblastosis

Who this might be right for
Acute Lymphoblastic LeukemiaMyeloblastic LeukemiaBiphenotypic Acute Leukemia+3 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 56
Not applicableActive Not RecruitingNCT04231500
What this trial is testing

The Skin Microbiome in Graft Versus Host Disease

Who this might be right for
Skin MicrobiomeGraft Versus Host DiseaseGraft Versus Host Disease in Skin
University Hospital, Basel, Switzerland 74
Testing effectiveness (Phase 2)UnknownNCT04969172
What this trial is testing

A Phase II Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Exosomes Overexpressing CD24 to Prevent Clinical Deterioration in Patients With Moderate or Severe COVID-19 Infection

Who this might be right for
COVID-19 Disease
Eli Sprecher, MD 155
Testing effectiveness (Phase 2)Study completedNCT01273207
What this trial is testing

Extension Study (Extended Access) of Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans

Who this might be right for
Bronchiolitis ObliteransConstructive BronchiolitisGraft Versus Host Disease+3 more
National Heart, Lung, and Blood Institute (NHLBI) 7
Testing effectiveness (Phase 2)UnknownNCT00447460
What this trial is testing

Treatment of Refractory (Acute or Chronic) Graft-Versus-Host Disease by the Infusion of Expanded in-Vitro Allogenic Mesenchymal Stem Cell

Who this might be right for
Graft-vs-Host Disease (GVHD)
University of Salamanca 15
Next Page